Karuna Therapeutics Inc logo

Karuna Therapeutics Inc

1
NAS:KRTX (USA)  
$ 320.25 +0.87 (+0.27%) 10:08 PM EST
At Loss
P/B:
9.68
Market Cap:
$ 12.22B
Enterprise V:
$ 10.93B
Volume:
334.29K
Avg Vol (2M):
1.01M
Also Trade In:
Volume:
334.29K
At Loss
Avg Vol (2M):
1.01M

Business Description

Description
Karuna Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by unmet medical needs. Its product candidate, KarXT is an oral modulator of muscarinic receptors that are located both in the central nervous system, or CNS, and various peripheral tissues.
Name Current Vs Industry Vs History
Cash-To-Debt 75.67
Equity-to-Asset 0.94
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 88.11
Distress
Grey
Safe
Beneish M-Score -9.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 72.73
9-Day RSI 68.56
14-Day RSI 71.45
6-1 Month Momentum % 82.55
12-1 Month Momentum % 64.94

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 19.31
Quick Ratio 19.31
Cash Ratio 18.54
Days Sales Outstanding 38.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12
Shareholder Yield % -3.59

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -75653.98
Net Margin % -66311.93
FCF Margin % -59439.76
ROE % -32.8
ROA % -31.55
ROIC % -2178.08
ROC (Joel Greenblatt) % -2897.19
ROCE % -37.16

Financials (Next Earnings Date:2024-05-03 Est.)

KRTX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:KRTX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Karuna Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.654
EPS (TTM) ($) -11.72
Beta 0.38
Volatility % 72
14-Day RSI 71.45
14-Day ATR ($) 2.223429
20-Day SMA ($) 317.0045
12-1 Month Momentum % 64.94
52-Week Range ($) 158.375 - 321.45
Shares Outstanding (Mil) 38.15

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Karuna Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Karuna Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Karuna Therapeutics Inc Frequently Asked Questions

What is Karuna Therapeutics Inc(KRTX)'s stock price today?
The current price of KRTX is $320.25. The 52 week high of KRTX is $321.45 and 52 week low is $158.38.
When is next earnings date of Karuna Therapeutics Inc(KRTX)?
The next earnings date of Karuna Therapeutics Inc(KRTX) is 2024-05-03 Est..
Does Karuna Therapeutics Inc(KRTX) pay dividends? If so, how much?
Karuna Therapeutics Inc(KRTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1